Document Detail

Bidirectional transfer of methadone across human placenta.
MedLine Citation:
PMID:  15588727     Owner:  NLM     Status:  MEDLINE    
Methadone maintenance programs are considered the standard of care for the pregnant opiate addict. However, data on changes in methadone pharmacokinetics (PK) during pregnancy are limited and do not include its disposition by the placenta due to obvious ethical and safety considerations. Accordingly, investigations in our laboratory are focusing on human placental disposition of opiates including methadone. Recently, we reported on methadone metabolism by placental aromatase and provide here data on its bidirectional transfer across the tissue utilizing the technique of dual perfusion of placental lobule. The concentrations of the opiate transfused into the term placental tissue were those reported for its in vivo levels in the maternal serum of women under treatment with the drug. Data obtained indicated that the opiate has no adverse effects on placental viability and functional parameters and that it is retained by the tissue. Also, methadone transfer and its clearance index in the fetal to maternal direction (0.97+/-0.05) was significantly higher (P<0.05) than in the maternal to fetal (0.83+/-0.09). The observed asymmetry in methadone transfer could be explained by the unidirectional activity of the efflux transporter P glycoprotein (P-gp) that is highly expressed in variable amounts in trophoblast tissue. Therefore, placental disposition of methadone might be an important contributor to the regulation of its concentration in the fetal circulation and consequently may affect the incidence and intensity of neonatal abstinence syndrome for women treated with the drug during pregnancy.
Ilona A Nekhayeva; Tatiana N Nanovskaya; Sujal V Deshmukh; Olga L Zharikova; Gary D V Hankins; Mahmoud S Ahmed
Related Documents :
2447327 - Diagnosis and monitoring of pregnancy in mice: correlations between maternal weight, fe...
8011817 - Use of amphotericin b during pregnancy: case report and review.
3513207 - Uptake, transfer and metabolism of prostaglandin e2 in the isolated perfused human plac...
4857497 - Placental permeability of lead.
23752507 - Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five...
16600227 - Use of a medium buffered with n-hydroxyethylpiperazine-n-ethanesulfonate (hepes) in int...
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Biochemical pharmacology     Volume:  69     ISSN:  0006-2952     ISO Abbreviation:  Biochem. Pharmacol.     Publication Date:  2005 Jan 
Date Detail:
Created Date:  2004-12-13     Completed Date:  2005-02-15     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0101032     Medline TA:  Biochem Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  187-97     Citation Subset:  IM    
Department of Obstetrics and Gynecology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555 0587, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Dose-Response Relationship, Drug
Maternal-Fetal Exchange / drug effects,  physiology*
Methadone / metabolism*,  pharmacology
Oxygen Consumption / drug effects,  physiology
Placenta / drug effects,  metabolism*
Grant Support
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Characterization of antinociceptive activity of novel endomorphin-2 and morphiceptin analogs modifie...
Next Document:  Inhibitory effect of protopine on K(ATP) channel subunits expressed in HEK-293 cells.